After 26 years of being classified as measles‑free, the United States has lost its elimination status, an independent commission of experts reporting to the Pan American Health Organization announced. The decision, first reported by The Wall Street Journal and confirmed to CNN, follows a sustained decline in vaccination coverage and a surge in cases, hospitalizations and deaths linked to the disease.
How Elimination Is Measured
The PAHO committee defines a disease as endemic when the same viral strain is transmitted continuously within a country for at least one year. Scientists determine this by comparing the genetic code of virus samples; each replication introduces tiny mutations that allow researchers to trace transmission chains. In August, Utah’s public‑health laboratory released a preprint showing that a single measles strain accounted for more than 95% of the state’s cases and had circulated for over a year, producing more than 600 infections between June 2025 and June 2026.
Scale of Recent Outbreaks
Beyond Utah, sustained outbreaks have been documented in South Carolina, Pennsylvania, Wisconsin and New York, as well as several other states. The United States has recorded more than 5,400 measles cases this year—the highest annual total since 1991. Those cases stem from 43 new outbreaks, with an additional 1,000 infections linked to clusters that began the previous year. Hospitalizations have occurred in roughly one out of every nine reported cases, and state health reports confirm at least ten deaths attributed to measles.
Implications and Next Steps
Public‑health officials stress that the loss of elimination status signals deeper vulnerabilities. Dr. Demetre Daskalakis, former director of the CDC’s National Center for Immunization and Respiratory Diseases, called measles elimination “a vital sign for our public‑health system” and warned that its loss exposes cracks in national preparedness. Dr. Nuwan Gunawardhana of Columbia University Irvine Medical Center described the situation as “devastating,” noting that it reverses a generation of progress.
Vaccination remains the primary defense. Two doses of the measles‑mumps‑rubella (MMR) vaccine reduce the risk of illness by 97% compared with being unvaccinated. Yet most of this year’s cases involve individuals who were not fully vaccinated or whose vaccination status is unknown. Experts such as Dr. William Moss of Johns Hopkins Bloomberg School of Public Health caution that measles can erase immune memory, predispose patients to pneumonia, diarrhea, and rare but fatal complications like subacute sclerosing panencephalitis.
Dr. Peter Hotez, co‑director of the Center for Vaccine Development at Texas Children’s Hospital, labeled the loss “incredibly embarrassing” and emphasized that the core issue is the resurgence of the virus, not the label itself. He warned that declining vaccination rates, expanding non‑medical exemptions, and eroding public trust make regaining elimination status a formidable challenge. Dr. Moss echoed this sentiment, noting that diminished confidence in vaccines and falling coverage among kindergarten students will require sustained effort to reverse.
Regionally, the United States remains one of the 30 diseases targeted for elimination by 2030 under PAHO. The Americas had achieved continent‑wide measles‑free status in 2016, a designation that Canada lost last year after a multi‑province outbreak and that Mexico now threatens to lose. Restoring U.S. elimination status will depend on reversing vaccination declines, strengthening school‑entry requirements, and rebuilding confidence in the safety and effectiveness of the MMR vaccine.
Steve Lopez is a Senior Editorial Columnist and Health & Public Policy reporter for News Raise. Steve focuses on healthcare advancements, medical technologies, and public health policies.




